Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Cash & Equivalents: 2010-2024

Historic Cash & Equivalents for Solesence (SLSN) over the last 15 years, with Dec 2024 value amounting to $1.4 million.

  • Solesence's Cash & Equivalents fell 85.33% to $429,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $429,000, marking a year-over-year decrease of 85.33%. This contributed to the annual value of $1.4 million for FY2024, which is 18.18% down from last year.
  • Solesence's Cash & Equivalents amounted to $1.4 million in FY2024, which was down 18.18% from $1.7 million recorded in FY2023.
  • Solesence's 5-year Cash & Equivalents high stood at $2.2 million for FY2022, and its period low was $657,000 during FY2021.
  • Over the past 3 years, Solesence's median Cash & Equivalents value was $1.7 million (recorded in 2023), while the average stood at $1.8 million.
  • As far as peak fluctuations go, Solesence's Cash & Equivalents plummeted by 31.35% in 2021, and later skyrocketed by 232.72% in 2022.
  • Solesence's Cash & Equivalents (Yearly) stood at $957,000 in 2020, then slumped by 31.35% to $657,000 in 2021, then spiked by 232.72% to $2.2 million in 2022, then fell by 21.23% to $1.7 million in 2023, then decreased by 18.18% to $1.4 million in 2024.